Dr. Klein testifies in state congress on behalf of physicians and patients

An ANA physician testified before the House of Representatives in Harrisburg, PA regarding House Bill 746, which addresses biosimilar medications.

Biosimilars are biologic medical products whose active drug substance is made by a living organism or derived from a living organism by means of recombinant DNA or controlled gene expression methods.

In short, this bill ensures that patients and physicians are made aware if the pharmacist substitutes a biosimilar product.

For further information, read the Pennsylvania Medical Society update.